系統的なRNAをデンドリット細胞に送り込むことで,抗ウイルス防御をがん免疫療法に活用する
Lena M Kranz1,2, Mustafa Diken1,3, Heinrich Haas3
1TRON-Translational Oncology at the University Medical Center of the Johannes Gutenberg University gGmbH, Freiligrathstr. 12, Mainz 55131, Germany.
Nature
|June 10, 2016
まとめ
静脈内投与されたRNA- リポプレックス (RNA- LPX) は,活力のあるT細胞応答を in vivo で効果的に標的とする. この新しいワクチンプラットフォームは 強い適応性および先天的な免疫を誘発し 癌の免疫療法に希望を示しています
科学分野:
- 免疫学
- ワクチン学
- ナノテクノロジー
背景:
- リンパ性臓器はT細胞のプリミングに最適ですが,系統的な抗原を dendritic cells (DCs) に送ることは困難です.
- ワクチンの開発には,DCを in vivo で効果的に標的化することが不可欠です.
研究 の 目的:
- RNA-リポプレックス (RNA-LPX) を用いたDCの正確で効果的なインビボ標的化のための方法を開発する.
- 癌の免疫療法におけるRNA-LPXの免疫性および治療の可能性を評価する.
主な方法:
- 静脈内投与のRNA-リポプレックス (RNA-LPX) は,DCターゲティングに最適化された純電荷である.
- リンパ系におけるRNA-LPX吸収,抗原発現,免疫応答の評価
- 臨床前モデルにおけるT細胞反応と腫瘍拒絶の評価
- メラノーマ患者の臨床試験
主要な成果:
- RNA-LPXは生物体内でDCとマクロファージを効果的に標的にし,RNAを保護し,抗原発現を可能にしました.
- RNA- LPXが誘発したインターフェロン- アルファ (IFNα) 放出,DC成熟,ウイルス様炎症反応.
- RNA- LPXは強いエフェクターと記憶T細胞の反応を誘導し,IFNα依存の腫瘍拒絶を媒介した.
- 早期の臨床試験データでは,IFNα誘導と強固な抗原特異性T細胞反応がメラノーマ患者で示された.
結論:
- 最適化されたRNA-LPXは,全身的なDCターゲティングに普遍的に適用されるワクチンクラスです.
- このプラットフォームは,がん免疫療法のための強力な適応性およびタイプI-IFN媒介性先天免疫を同期します.
- RNA-LPXは次世代がんワクチンの開発に重要な可能性を示しています.
関連する概念動画
Viruses with RNA Genomes
1.2K
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
1.2K
Immune Response Against Viral Pathogens
2.3K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
2.3K
Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Mechanisms of Retrovirus-induced Cancers
7.1K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
7.1K
Experimental RNAi
8.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
8.1K
Cytotoxic T Cells-mediated Immune Response
7.7K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.7K


